Navigation Links
Catalyst to Focus Resources on its Lead Indication for CPP-109; Cocaine Addiction
Date:3/3/2009

CORAL GABLES, Fla., March 3 /PRNewswire/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a biopharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced modifications to its previously announced product development program. In order to extend its cash resources well into 2010, Catalyst has decided to halt enrollment of new subjects into its ongoing U.S. Phase II trial evaluating CPP-109 for the treatment of methamphetamine addiction and will instead convert that trial to a smaller proof-of-concept study. Catalyst will continue to treat the approximately 55 subjects currently in the trial for the 13 week active phase as described in the trial protocol. As previously announced, Catalyst's Phase II cocaine trial is now fully enrolled, with 186 patients at 11 leading addiction research facilities around the United States, and top-line results from the cocaine trial are expected to be available during the second quarter of 2009.

Patrick J. McEnany, Catalyst's Chairman and Chief Executive Officer, stated, "We believe that this modification to our clinical development program is prudent in light of the capital markets and economic environment that currently exists. Our immediate and primary focus continues to be on concluding the Phase II trial evaluating our lead candidate CPP-109 for the treatment of cocaine addiction. Furthermore, this modification does not change the previously announced timetable as it relates to Catalyst's intention to file a New Drug Application with the FDA to obtain the right to market CPP-109 for the treatment of cocaine addiction. With the restructuring of our clinical development programs, we will now have sufficient working capital for the next 18-24 months. The extension of our cash resources also allows us more time t
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The Catalyst Foundations Groundbreaking ACE Study-Based Services Bring Transformational Change to Healthcare
2. Upcoming Packard/Stanford Autism Symposium a Catalyst for Collaboration among Researchers and Community
3. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
4. Catalyst mystery unlocked
5. CATalyst Council Forms to Address Feline Health Care
6. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
7. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
8. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
9. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
10. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
11. CATalyst Summit Declared a Success: Its All About the Cat!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... (PRWEB) September 17, 2014 Wright ... Conserve line of metal-on-metal hip replacements continue to ... U.S. District Court, Northern District of Georgia, Bernstein ... List issued by the U.S. Judicial Panel on ... 397 product liability claims have been filed in ...
(Date:9/17/2014)... TX (PRWEB) September 17, 2014 Smart ... Editor’s Picks by Progressive Grocer, a leading trade magazine ... was awarded for originality and flavor, among other attributes. ... as an Editor’s Pick in the September print issue ... Grocer website. , The pizza won based on its ...
(Date:9/17/2014)... Suwanee, GA (PRWEB) September 17, 2014 ... proud to announce the launch of its new vegan ... mask is extremely effective and provided the results skincare ... was to create a gentle yet active mask that ... CEO Lake Louise.” , This Sugar Cane Fruit Mask ...
(Date:9/17/2014)... -- Present-day Europeans are the descendants of at ... a new study. Previous research suggested ... European farmers. But, a new genetic analysis involving ... descendants of Ancient North Eurasians. Nearly all present-day ... group, researchers from Harvard Medical School said. , ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, ... who turn to artificial sweeteners to soothe their sweet ... new Israeli study suggests. Artificial sweeteners can potentially ... researchers found in human and mouse studies. That,s ... bacteria residing in the intestines in ways that can ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2Health News:EcoBeauty Brand Lotus Moon Unveils New Gluten-Free Sugar Cane Fruit Mask 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3
... in what triggers jealousy in men and women, study finds ... in the eye of the beholder, a new study suggests. ... to men while emotional infidelity may be of greater concern ... experiences in previous relationships may be even more important. , ...
... notes bloating, stomach pain, fatigue also point to less ... Relying on symptoms alone to identify women who have ... early, a new study indicates. , Research shows that ... healthy women to report symptoms such as abdominal pain, ...
... Jan. 28 Baylor Sammons Breast Center at ... has been recognized by the National Accreditation Program for Breast ... every significant advantage in their battle against breast disease." The ... NAPBC. Accreditation by the NAPBC is only given to those ...
... , ST. PAUL, Minn. , Jan. 28 ... -based Campbell Mithun, has been named Event Chair for this year’s ... Minnesota’s only nonprofit organization to supply life-saving blood and blood components ... to have Jeff Naughtin on board to head this ...
... , TORRANCE, Calif. , Jan. 28 ... is often a renewed focus on personal health and nutrition. ... year are prebiotics and immune health. This is welcome news ... addresses both categories. , SPINS, the leading provider of ...
... past or future, study finds , THURSDAY, Jan. 28 (HealthDay ... look toward the future, their body language reflects their sense ... the University of Aberdeen fitted subjects with motion sensors and ... past. The bodies of those who thought about the future ...
Cached Medicine News:Health News:Personal History Linked to Feelings of Betrayal 2Health News:Symptoms Alone Don't Spot Ovarian Cancer Early 2Health News:Symptoms Alone Don't Spot Ovarian Cancer Early 3Health News:Breast Center at Baylor Dallas Recognized for Commitment to Fighting Breast Disease 2Health News:Breast Center at Baylor Dallas Recognized for Commitment to Fighting Breast Disease 3Health News:Memorial Blood Centers Names Campbell Mithun’s Jeff Naughtin Event Chair for What’s Your Type? Benefit 2Health News:Memorial Blood Centers Names Campbell Mithun’s Jeff Naughtin Event Chair for What’s Your Type? Benefit 3Health News:Sun Chlorella USA Positioned for Strong 2010 2
(Date:9/17/2014)... EMERYVILLE, Calif. , Sept. 17, 2014 /PRNewswire/ ... newest data analytics solution that brings complete visibility ... minimize risks in an ever-evolving reimbursement landscape. Powered ... Integrity brings transparency to the critical point between ... operations impact revenue. The solution will improve revenue ...
(Date:9/17/2014)... MADISON, Tenn. , Sept. 17, 2014 ... be; these infections are not only uncomfortable, they,re often ... best-laid social plans. pH-D Feminine Health Support ( http://ph-defense.com ... vaginal health. It is an all-natural, homeopathic product. ... the most common symptoms of vaginal infection. In many ...
(Date:9/17/2014)... , Sept. 17, 2014  Aratana Therapeutics, Inc. ... company focused on licensing, developing and commercializing innovative ... pricing of its public offering of 4,500,000 shares of its ... of $9.25 per share. Aratana has granted the ... an additional 675,000 shares of its common stock. ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3New Product from Vireo Systems: pH-D Feminine Health Support 2Aratana Therapeutics, Inc. Announces Pricing of Public Offering 2
... DELAND, Fla., May 13 USHIFU, LLC, the clinical ... pleased,to announce conditional written approval pending minor changes to ... for the treatment of,recurrent prostate cancer with the Sonablate(R) ... Dr. Herbert Lepor, Chairman of Urology at NYU ...
... Products Expand Infection Prevention Business, DUBLIN, Ohio, ... products and services that improve the safety and,productivity ... the,acquisition of assets of privately held Enturia, Inc., ... ChloraPrep(R) brand name., ChloraPrep(R) brand products are ...
Cached Medicine Technology:FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer 2Cardinal Health Completes Enturia Acquisition 2
... Digital Wide Field Lens combines ... high magnification. The enhanced double ... provide high resolution stereo views ... reflections. These unique features make ...
... Stereo Fundus Lens is specifically designed for ... retina. Its enhanced 3-D stereoscopic design enables ... detail, making it ideal for detecting changes ... serous detachments and other macular abnormalities. It ...
The Pan Retinal® 2.2 uniquely combines magnification nearly that of the 20D lens with a field of view approaching that of the 30D lens. Excellent for virtually every examination procedure, includ...
... Volks state-of-the-art 20D diagnostic/laser lens ... astigmatic aberrations and coma delivering ... 20 diopter lens on the market. ... maintains linear image magnification and perfect ...
Medicine Products: